NASDAQ$INGN

Inogen Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Reported an increase in revenue driven by higher demand and new customer gains, offset by lower direct-to-consumer sales. Achieved positive adjusted EBITDA and a reduced net loss compared to the previous year.

Inogen reported a 5.8% increase in revenue to $88.8 million, driven by growth in the business-to-business channels. The company's gross margin improved to 46.5%, and operating expenses decreased due to a one-time goodwill impairment charge in the previous year. GAAP net loss was $6.0 million, with adjusted EBITDA at $0.5 million.

  • Total revenue increased by 5.8% to $88.8 million compared to Q3 2023.
  • Gross margin improved to 46.5% due to lower raw material costs.
  • Operating expenses decreased by 39.0% due to a one-time goodwill impairment charge in the prior year period.
  • GAAP net loss improved to $6.0 million, and adjusted EBITDA was a positive $0.5 million.

Headline financials

Total Revenue

$88.8M

Previous: $84M+5.8%
EPS

-$0.25

Previous: -$0.36+30.6%
Units Sold

43.9K

Previous: 35.4K+24.0%
Net Rental Patients

51.4K

Previous: 51.9K-1.0%
Capital Expenditures

-$3.03M

Previous: -$3.82M+20.7%
Free Cash Flow

-$8.99M

Previous: -$49.5M+81.8%
Net Income

-$5.96M

Previous: -$45.7M+87.0%
Operating Income

-$7.79M

Previous: -$46.7M+83.3%
Gross Profit

$41.3M

Previous: $33.8M+22.4%
R&D Expense

$3.52M

Previous: $4.28M-17.9%
Stock-Based Comp

$1.47M

Previous: $1.78M-17.1%

Revenue & EPS history

Inogen · Revenue · Quarterly

$88.8M

Q3 2024+5.8%vs Q3 2023
Beat estimate in 10 of 14 quarters(71%)
ActualEstimate

Forward guidance

Inogen now expects revenue for the full year 2024 to range from approximately $329 million to $331 million, which represents approximately 4% to 5% growth over the Company’s prior year revenue.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-0.7%

Avg return

Earnings day

-2.0%

Avg return

5 days after

-2.0%

Avg return

30 days after

49%

26 / 53 earnings

Positive

+35.5%

Q2 2024

Best reaction

-32.2%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.4%-5.3%-11.0%
Q4 2025+4.3%+5.8%+6.0%
Q3 2025-0.6%+0.9%-1.3%
Q1 2025-11.5%-14.4%-8.1%
Q4 2024-14.8%-14.6%-28.6%
Q3 2024+15.9%+9.1%-0.7%
Q2 2024+35.5%+50.6%+43.0%
Q1 2024+14.6%+17.7%+17.7%
Q4 2023-32.2%-24.3%-13.0%
Q3 2023-1.3%-8.1%+10.0%
Q2 2023-14.6%-18.7%-20.8%
Q1 2023-6.1%-19.3%-21.9%
Q4 2022-31.4%-32.4%-46.4%
Q3 2022-12.5%-10.0%-0.8%
Q2 2022-6.9%-7.3%-6.3%
Q1 2022-2.2%-7.8%+2.0%
Q4 2021+12.6%+25.3%+13.5%
Q3 2021-6.0%-7.3%-21.6%
Q2 2021-22.8%-16.8%-22.1%
Q1 2021-3.5%-2.4%-12.8%
Q4 2020+4.6%+5.4%-4.2%
Q3 2020-7.1%+9.8%+33.0%
Q2 2020+16.4%+17.0%-6.5%
Q1 2020-21.4%-20.1%-24.2%
Q4 2019+10.2%+5.4%+26.4%
Q3 2019+17.3%+19.7%+24.4%
Q2 2019-15.4%-18.5%-20.9%
Q1 2019-28.8%-22.2%-31.8%
Q4 2018-26.4%-25.9%-35.1%
Q3 2018-18.8%-22.6%-24.8%
Q2 2018+7.7%+6.3%+21.3%
Q1 2018+21.0%+18.7%+26.7%
Q4 2017-9.3%-8.4%-7.8%
Q3 2017+16.1%+12.9%+15.0%
Q2 2017-5.6%-3.9%+0.3%
Q1 2017+0.2%-2.6%+11.9%
Q4 2016+6.8%+6.0%+11.4%
Q3 2016+13.0%+15.8%+22.3%
Q2 2016+0.9%+9.3%+8.9%
Q1 2016-6.6%
Q4 2015+20.6%
Q3 2015-1.8%
Q2 2015+13.0%
Q1 2015+4.9%
Q4 2014+1.8%
Q4 2012+1.8%
Q3 2013-1.7%
Q3 2014+6.0%
Q2 2014+3.6%
Q2 2013+3.6%
Q1 2013+12.7%
Q1 2014+12.7%
Q4 2013-1.0%
Q3 2012

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro